|
News
:
LUMBY, BC Canada, Aug. 31 /PRNewswire-FirstCall/ -- avVaa World Health
Care Products Inc. (OTC Bulletin Board: AVVW), a global biotechnology
company offering therapeutic natural skin and health care products,
announced today that it has developed a Wholesale and Internet Sales
Division of avVaa World Health Care Products, Inc. with Customer Sales &
Service Agents.
avVaa has established this division in response to mounting orders for NeuroSkin Spray Eczema/Psoriasis Relief & NeuroSkin Acne Treatment Spray as
a result of the Company's recent national advertising campaign as well as
additional planned campaigns. Orders resulting from the print ad campaign
have been received through the Company's call center and website. avVaa EVP Sales and Marketing and Advisor to the Board Lorie
Campbell-Farley said, "Our Customer Sales and Service Agents are working to
sell products to the 17 million Americans that have acne, 17 million+ that
are suffering from psoriasis and over 16 million people living in the
United States that are effected by eczema." Research by the National Psoriasis Association has shown that 30%
percent of Americans have dermatological conditions. The USA Dermatologists
Association and other institutions indicate that close to $4 billion is
spent on treatment for psoriasis, eczema and acne annually.
Campbell-Farley continued, "We have established a customer base through
these orders and our Customer Sales and Service Agents will be contacting
each of them to encourage refill orders. Follow-up calls to our established
customer base will provide consumers with convenient re-ordering and
provide personal one-on-one contact. Our trained Customer Sales & Service
Agents will provide a full range of services to our retailers and consumers
for both Internet and Wholesale orders." avVaa also announced that it plans to introduce another advertising
campaign the third week of September, 2006 to continue to build brand and
product recognition by placing ads in major North American publications. In
response, the Company expects to rapidly develop a customer base that will
order on a regular basis (1000 by the end of November with an average sale
of 2 bottles at $50.00).
In addition, avVaa is continuing its focus on the $42 billion pet industry and $39 billion equine industry, targeting advertising in
economical regional industry magazines for both consumers and retailers.
The Company's Customer Sales and Service Agents process orders and follow
up on inquiries as a result of avVaa's pet and equine related ad campaigns.
Buyers for retail stores across Canada are also being personally contacted
and provided with product information in a direct wholesale approach by
avVaa Customer Sales and Service Agents. Barb Hazell, VP Animal Care said, "We are excited by the results of
recent advertising for avVaa's comprehensive animal care line that is now
featured in various equine and pet magazines, have a quick read format to
help time-challenged consumers and retailers quickly find the information
on dermalustre (R) Professional Skin and Coat Treatment for pets and
equine. A consistent ad campaign will allow us to show a strong presence to
the industry, while building brand awareness among our consumers."
About avVaa World Health Care Products
avVaa World Health Care Products (AVVW) is a global biotechnology company that specializes in effective, all natural, therapeutic skin care
products that improve quality of life and well being for consumers. avVaa's
patented European skin care formulas are scientifically registered,
FDA-Compliant, and were developed to relieve and treat the symptoms of
common skin ailments, including: eczema, psoriasis and acne. avVaa is
poised to manufacture and market its OTC Neuroskin line of skin care
products through mass food and drug channels in the United States and
globally.
Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such
forward-looking statements are subject to risks and uncertainties, which
could cause actual results to differ materially from estimated results.
Management cautions that all statements as to future results of operations
are necessarily subject to risks, uncertainties, and events that may be
beyond the control of AVVAA World Health Care Products, Inc. and no
assurance can be given that such results will be achieved. Potential risks
and uncertainties include but are not limited to the ability to procure,
properly price, retain, and successfully complete projects, the
availability of technical personnel, changes in technology, and
competition.
For additional information on avVaa contact Jack Farley CEO / Chairman,
at 1-866-772-8822 or visit: http://www.avvaa.com or
http://www.otcfn.com/avvw
|
